Conferences
12–13 June 2017, Hotel Palace Berlin, Berlin, Germany
18th Annual Drug Discovery Summit, 12-13 June 2017
This congress brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions.
Our event will have over 55 presentations and case studies and panel discussions focused on the key issues in drug discovery and medicinal chemistry.
Including 6 interactive streams
- Drug Discovery Innovation and Strategies, Enabling Technologies
- Novel Drug Target Discovery for Immuno-Therapy, Autoimmune Diseases and Oncology
- Successful Phenotypic Drug Discovery: High Content Screening
- RNAi Screening, Cancer Genomics and Gene Editing for Drug Discovery
- Discovery Chemistry, Medicinal and Computational Chemistry
- Medicinal Chemistry and Drug Design: Novel Approaches.
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.
Co-located with our 5th Annual Discovery Chemistry and Drug Design Congress and our inaugural Microbiome Discovery and Development Congress
Free Webinars available:
Drug Discovery Open Innovation & Outsourcing
Hosted by Patrick Kleyn, Director of Drug Target Innovation, EMD Serono
Register for Free Today: http://bit.ly/2f046Yl
Phenotypic Screening in Drug Discovery- Novel Tools & Applications
Hosted by Paul Andrews, Director of Operations, National Phenotypic Screening Centre (NPSC), School of Life Sciences, University of Dundee
Register for Free Today: http://bit.ly/2f44Xpd
Disruptive Technologies & Artificial Intelligence in Drug Discovery
Hosted by Chris Gibson, CEO, Recursion Pharmaceuticals
Register for Free Today: http://bit.ly/2f4a34F
You can also follow us on Twitter @drugdiscovery1 and join the congress conversation on #DDSummit17
For further information on the congress and the webinars, please contact Guillaume Alonso on [email protected] or call +44 (0) 1865 248 455.
